USD 181.27
(-0.29%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 8.15 Billion USD | 8.38% |
2022 | 7.52 Billion USD | 9.12% |
2021 | 6.89 Billion USD | -2.47% |
2020 | 7.07 Billion USD | 16.19% |
2019 | 6.08 Billion USD | 5.0% |
2018 | 5.79 Billion USD | 1.61% |
2017 | 5.7 Billion USD | -0.13% |
2016 | 5.71 Billion USD | 12.37% |
2015 | 5.08 Billion USD | 2.8% |
2014 | 4.94 Billion USD | 3.14% |
2013 | 4.79 Billion USD | -7.83% |
2012 | 5.2 Billion USD | 1.98% |
2011 | 5.09 Billion USD | -7.35% |
2010 | 5.5 Billion USD | 178.7% |
2009 | 1.97 Billion USD | 0.15% |
2008 | 1.97 Billion USD | 4.82% |
2007 | 1.88 Billion USD | 10.63% |
2006 | 1.7 Billion USD | 13.84% |
2005 | 1.49 Billion USD | -7.55% |
2004 | 1.61 Billion USD | 6.14% |
2003 | 1.52 Billion USD | 19.73% |
2002 | 1.27 Billion USD | 7.68% |
2001 | 1.18 Billion USD | 30.47% |
2000 | 905.01 Million USD | 22.17% |
1999 | 740.8 Million USD | 7.1% |
1998 | 691.7 Million USD | 23.81% |
1997 | 558.7 Million USD | 8.95% |
1996 | 512.8 Million USD | 13.85% |
1995 | 450.4 Million USD | 72.63% |
1994 | 260.9 Million USD | 10.6% |
1993 | 235.9 Million USD | -12.47% |
1992 | 269.5 Million USD | -14.8% |
1991 | 316.3 Million USD | -13.96% |
1990 | 367.6 Million USD | -0.11% |
1989 | 368 Million USD | -4.81% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 7.67 Billion USD | 2.02% |
2024 Q1 | 7.73 Billion USD | -5.15% |
2024 Q2 | 7.51 Billion USD | -2.85% |
2023 Q4 | 8.15 Billion USD | 5.06% |
2023 FY | 8.15 Billion USD | 8.38% |
2023 Q1 | 7.49 Billion USD | -0.33% |
2023 Q2 | 7.59 Billion USD | 1.33% |
2023 Q3 | 7.76 Billion USD | 2.14% |
2022 Q4 | 7.52 Billion USD | 0.72% |
2022 Q1 | 7.17 Billion USD | 4.09% |
2022 Q2 | 7.38 Billion USD | 2.93% |
2022 Q3 | 7.47 Billion USD | 1.12% |
2022 FY | 7.52 Billion USD | 9.12% |
2021 Q2 | 6.23 Billion USD | -3.92% |
2021 FY | 6.89 Billion USD | -2.47% |
2021 Q1 | 6.49 Billion USD | -8.21% |
2021 Q3 | 6.47 Billion USD | 3.82% |
2021 Q4 | 6.89 Billion USD | 6.51% |
2020 FY | 7.07 Billion USD | 16.19% |
2020 Q1 | 6.13 Billion USD | 0.76% |
2020 Q2 | 6.38 Billion USD | 4.1% |
2020 Q3 | 6.97 Billion USD | 9.21% |
2020 Q4 | 7.07 Billion USD | 1.43% |
2019 Q1 | 6.16 Billion USD | 6.38% |
2019 Q4 | 6.08 Billion USD | -0.67% |
2019 Q2 | 6.28 Billion USD | 1.93% |
2019 Q3 | 6.12 Billion USD | -2.51% |
2019 FY | 6.08 Billion USD | 5.0% |
2018 Q1 | 5.73 Billion USD | 0.49% |
2018 FY | 5.79 Billion USD | 1.61% |
2018 Q4 | 5.79 Billion USD | -0.56% |
2018 Q3 | 5.82 Billion USD | 2.74% |
2018 Q2 | 5.67 Billion USD | -1.02% |
2017 FY | 5.7 Billion USD | -0.13% |
2017 Q2 | 5.66 Billion USD | 0.52% |
2017 Q1 | 5.63 Billion USD | -1.27% |
2017 Q3 | 5.7 Billion USD | 0.61% |
2017 Q4 | 5.7 Billion USD | 0.03% |
2016 Q4 | 5.71 Billion USD | 9.8% |
2016 Q3 | 5.2 Billion USD | 0.72% |
2016 Q2 | 5.16 Billion USD | 4.28% |
2016 Q1 | 4.95 Billion USD | -2.56% |
2016 FY | 5.71 Billion USD | 12.37% |
2015 Q3 | 4.76 Billion USD | 1.21% |
2015 Q2 | 4.7 Billion USD | -3.27% |
2015 Q1 | 4.86 Billion USD | -1.59% |
2015 Q4 | 5.08 Billion USD | 6.71% |
2015 FY | 5.08 Billion USD | 2.8% |
2014 Q2 | 4.71 Billion USD | -0.88% |
2014 Q3 | 5.07 Billion USD | 7.54% |
2014 Q4 | 4.94 Billion USD | -2.54% |
2014 Q1 | 4.75 Billion USD | -0.71% |
2014 FY | 4.94 Billion USD | 3.14% |
2013 FY | 4.79 Billion USD | -7.83% |
2013 Q4 | 4.79 Billion USD | -3.58% |
2013 Q3 | 4.97 Billion USD | -1.37% |
2013 Q2 | 5.04 Billion USD | -2.99% |
2013 Q1 | 5.19 Billion USD | -0.11% |
2012 FY | 5.2 Billion USD | 1.98% |
2012 Q1 | 5.07 Billion USD | -0.48% |
2012 Q4 | 5.2 Billion USD | 6.49% |
2012 Q2 | 4.94 Billion USD | -2.62% |
2012 Q3 | 4.88 Billion USD | -1.19% |
2011 Q4 | 5.09 Billion USD | -0.47% |
2011 FY | 5.09 Billion USD | -7.35% |
2011 Q1 | 5.25 Billion USD | -0.8% |
2011 Q2 | 5.11 Billion USD | -2.52% |
2011 Q3 | 5.12 Billion USD | 0.11% |
2010 Q1 | 1.93 Billion USD | -2.13% |
2010 FY | 5.5 Billion USD | 178.7% |
2010 Q3 | 2.27 Billion USD | 10.68% |
2010 Q4 | 5.29 Billion USD | 132.17% |
2010 Q2 | 2.05 Billion USD | 6.56% |
2009 FY | 1.97 Billion USD | 0.15% |
2009 Q3 | 1.93 Billion USD | 1.27% |
2009 Q1 | 1.99 Billion USD | -9.13% |
2009 Q2 | 1.9 Billion USD | -4.45% |
2009 Q4 | 1.97 Billion USD | 2.16% |
2008 Q3 | 2.13 Billion USD | 9.42% |
2008 Q4 | 2.19 Billion USD | 3.12% |
2008 FY | 1.97 Billion USD | 4.82% |
2008 Q1 | 1.97 Billion USD | 5.03% |
2008 Q2 | 1.94 Billion USD | -1.39% |
2007 Q2 | 1.81 Billion USD | -0.08% |
2007 Q4 | 1.88 Billion USD | 1.11% |
2007 FY | 1.88 Billion USD | 10.63% |
2007 Q3 | 1.86 Billion USD | 2.4% |
2007 Q1 | 1.81 Billion USD | 6.95% |
2006 Q1 | 1.56 Billion USD | 4.46% |
2006 FY | 1.7 Billion USD | 13.84% |
2006 Q4 | 1.7 Billion USD | 16.03% |
2006 Q3 | 1.46 Billion USD | 2.1% |
2006 Q2 | 1.43 Billion USD | -8.0% |
2005 Q1 | 1.51 Billion USD | -6.05% |
2005 Q2 | 1.31 Billion USD | -13.52% |
2005 Q3 | 1.35 Billion USD | 3.42% |
2005 Q4 | 1.49 Billion USD | 10.03% |
2005 FY | 1.49 Billion USD | -7.55% |
2004 FY | 1.61 Billion USD | 6.14% |
2004 Q1 | 1.65 Billion USD | 8.62% |
2004 Q2 | 1.6 Billion USD | -3.19% |
2004 Q4 | 1.61 Billion USD | 2.47% |
2004 Q3 | 1.57 Billion USD | -1.49% |
2003 FY | 1.52 Billion USD | 19.73% |
2003 Q1 | 1.35 Billion USD | 6.33% |
2003 Q2 | 1.3 Billion USD | -3.71% |
2003 Q3 | 1.25 Billion USD | -3.79% |
2003 Q4 | 1.52 Billion USD | 21.54% |
2002 FY | 1.27 Billion USD | 7.68% |
2002 Q3 | 1.17 Billion USD | -0.5% |
2002 Q4 | 1.27 Billion USD | 8.14% |
2002 Q2 | 1.18 Billion USD | -2.64% |
2002 Q1 | 1.21 Billion USD | 2.78% |
2001 Q4 | 1.18 Billion USD | 9.18% |
2001 FY | 1.18 Billion USD | 30.47% |
2001 Q2 | 1.07 Billion USD | -4.2% |
2001 Q3 | 1.08 Billion USD | 0.52% |
2001 Q1 | 1.12 Billion USD | 24.11% |
2000 FY | 905.01 Million USD | 22.17% |
2000 Q4 | 905.01 Million USD | 1.66% |
2000 Q3 | 890.22 Million USD | 22.8% |
2000 Q2 | 724.94 Million USD | -3.03% |
2000 Q1 | 747.57 Million USD | 0.91% |
1999 Q4 | 740.8 Million USD | 2.24% |
1999 Q3 | 724.6 Million USD | 1.5% |
1999 Q2 | 713.9 Million USD | 1.77% |
1999 FY | 740.8 Million USD | 7.1% |
1999 Q1 | 701.5 Million USD | 1.42% |
1998 Q4 | 691.7 Million USD | -17.91% |
1998 Q1 | 868.3 Million USD | 55.41% |
1998 Q2 | 840.5 Million USD | -3.2% |
1998 Q3 | 842.6 Million USD | 0.25% |
1998 FY | 691.7 Million USD | 23.81% |
1997 Q3 | 571.7 Million USD | 12.43% |
1997 FY | 558.7 Million USD | 8.95% |
1997 Q1 | 511.9 Million USD | -0.18% |
1997 Q2 | 508.5 Million USD | -0.66% |
1997 Q4 | 558.7 Million USD | -2.27% |
1996 Q2 | 526 Million USD | 16.35% |
1996 Q3 | 519.2 Million USD | -1.29% |
1996 Q4 | 512.8 Million USD | -1.23% |
1996 Q1 | 452.1 Million USD | 0.38% |
1996 FY | 512.8 Million USD | 13.85% |
1995 Q3 | 451.5 Million USD | 75.68% |
1995 Q4 | 450.4 Million USD | -0.24% |
1995 FY | 450.4 Million USD | 72.63% |
1995 Q1 | 266.3 Million USD | 2.07% |
1995 Q2 | 257 Million USD | -3.49% |
1994 Q4 | 260.9 Million USD | 12.89% |
1994 Q1 | 241.2 Million USD | 2.25% |
1994 Q2 | 218.3 Million USD | -9.49% |
1994 Q3 | 231.1 Million USD | 5.86% |
1994 FY | 260.9 Million USD | 10.6% |
1993 Q2 | 259.1 Million USD | -3.64% |
1993 FY | 235.9 Million USD | -12.47% |
1993 Q3 | 258.2 Million USD | -0.35% |
1993 Q4 | 235.9 Million USD | -8.64% |
1993 Q1 | 268.9 Million USD | -0.22% |
1992 Q4 | 269.5 Million USD | 2.71% |
1992 Q3 | 262.4 Million USD | -4.2% |
1992 Q2 | 273.9 Million USD | -6.99% |
1992 FY | 269.5 Million USD | -14.8% |
1992 Q1 | 294.5 Million USD | -6.89% |
1991 FY | 316.3 Million USD | -13.96% |
1991 Q4 | 316.3 Million USD | -5.07% |
1991 Q1 | 337.6 Million USD | -8.16% |
1991 Q2 | 324.5 Million USD | -3.88% |
1991 Q3 | 333.2 Million USD | 2.68% |
1990 Q2 | 362 Million USD | 0.0% |
1990 FY | 367.6 Million USD | -0.11% |
1990 Q3 | 366.3 Million USD | 1.19% |
1990 Q4 | 367.6 Million USD | 0.35% |
1989 Q4 | 368 Million USD | 0.0% |
1989 FY | 368 Million USD | -4.81% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Phreesia, Inc. | 119.63 Million USD | -6716.462% |
Accuray Incorporated | 423.54 Million USD | -1825.411% |
Align Technology, Inc. | 2.45 Billion USD | -232.395% |
Elevance Health Inc. | 69.52 Billion USD | 88.27% |
AxoGen, Inc. | 101.16 Million USD | -7961.27% |
Boston Scientific Corporation | 15.6 Billion USD | 47.745% |
CVS Health Corporation | 173.09 Billion USD | 95.289% |
Cardinal Health, Inc. | 48.33 Billion USD | 83.128% |
Centene Corporation | 58.68 Billion USD | 86.104% |
DaVita Inc. | 14.87 Billion USD | 45.181% |
HCA Healthcare, Inc. | 55.15 Billion USD | 85.213% |
Hologic, Inc. | 4.02 Billion USD | -102.557% |
Humana Inc. | 30.74 Billion USD | 73.477% |
IDEXX Laboratories, Inc. | 1.77 Billion USD | -359.331% |
Laboratory Corporation of America Holdings | 8.83 Billion USD | 7.693% |
Masimo Corporation | 1.67 Billion USD | -386.369% |
McKesson Corporation | 69.04 Billion USD | 88.188% |
Patterson Companies, Inc. | 1.89 Billion USD | -330.34% |
Quest Diagnostics Incorporated | 7.6 Billion USD | -7.245% |
ResMed Inc. | 2 Billion USD | -306.052% |
Henry Schein, Inc. | 5.42 Billion USD | -50.46% |
Teladoc Health, Inc. | 2.06 Billion USD | -294.665% |
Veeva Systems Inc. | 1.26 Billion USD | -544.101% |
Baxter International Inc. | 19.8 Billion USD | 58.83% |
Becton, Dickinson and Company | 26.98 Billion USD | 69.779% |
Intuitive Surgical, Inc. | 2.04 Billion USD | -298.931% |
Danaher Corporation | 30.99 Billion USD | 73.692% |
Stryker Corporation | 21.31 Billion USD | 61.748% |
Medtronic plc | 39.56 Billion USD | 79.386% |